Ann E. McCullough
The Open Group(GB)
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Breast Cancer Treatment Studies, Cancer Genomics and Diagnostics, Breast Lesions and Carcinomas, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Trial(2015)371 cited
- → Integrated Genomic Characterization Reveals Novel, Therapeutically Relevant Drug Targets in FGFR and EGFR Pathways in Sporadic Intrahepatic Cholangiocarcinoma(2014)336 cited
- → Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer(2019)304 cited
- → Genomic Analysis Reveals That Immune Function Genes Are Strongly Linked to Clinical Outcome in the North Central Cancer Treatment Group N9831 Adjuvant Trastuzumab Trial(2015)203 cited
- → Androgen Receptor-Positive Triple Negative Breast Cancer: A Unique Breast Cancer Subtype(2013)166 cited
- → Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing(2013)158 cited
- → Folate Receptor-α (FOLR1) Expression and Function in Triple Negative Tumors(2015)146 cited
- → Detection of Coccidioides Species in Clinical Specimens by Real-Time PCR(2006)146 cited
- → Genomic amplification of 9p24.1 targeting JAK2, PD-L1, and PD-L2 is enriched in high-risk triple negative breast cancer(2015)135 cited
- → MR Imaging of Hypervascular Liver Masses: A Review of Current Techniques(2009)111 cited